Temporary Declines and Demand Resurgence: Gender-Affirming Surgery Volume and Complication Trends During and After the COVID-19 Pandemic

被引:3
作者
Miller, Amitai S. [1 ,2 ,3 ]
Beagles, Clay B. [1 ]
Kaur, Manraj N. [1 ,3 ]
Marano, Andrew A. [4 ]
Hu, Sophia [3 ,4 ]
Ghoshal, Soham [1 ,7 ]
Dey, Tanujit [5 ]
Coon, Devin [1 ,4 ]
Succi, Marc D. [1 ,6 ,7 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Harvard Univ, John Kennedy Sch Govt, Cambridge, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Patient Reported Outcomes Value & Experience PROVE, Dept Surg, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Plast & Reconstruct Surg, Boston, MA USA
[5] Harvard Med Sch, Ctr Surg & Publ Hlth, Brigham & Womens Hosp, Dept Surg, Boston, MA USA
[6] Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St, Boston, MA 02114 USA
[7] Massachusetts Gen Hosp, Innovat Operat Res Ctr MESH IO, Medically Engn Solut Healthcare Incubator, Boston, MA 02114 USA
关键词
Gender-affirming surgery; COVID-19; pandemic; Volume trends; Complications; Outcomes; Barriers; Surgical access; Disparities; TRANSGENDER; HEALTH; READABILITY; OUTCOMES; QUALITY; CARE;
D O I
10.1007/s00266-024-04243-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundThe COVID-19 pandemic prompted surgical volume reductions due to lockdown measures. This study evaluates COVID-19's impact on gender-affirming surgery (GAS) volume and complications from the pandemic onset through the recovery period.MethodsThe 2019-2021 National Surgical Quality Improvement Program databases were queried for transgender or gender-diverse patients using ICD-10 codes. Five time periods were analyzed: Pre-pandemic, Immediate pre-pandemic and COVID-19 outbreak, Initial COVID-19 peak, Pre-COVID-19 vaccine, and Post-vaccine release. Complications included reoperation, urinary tract infections, and wound complications. Multivariate logistic regressions assessed factors associated with undergoing surgery during the initial COVID-19 peak and experiencing surgical complications.ResultsOut of 2,963,230 patients, 4637 underwent GAS between 2019 and 2021. Chest feminizing and masculinizing procedures comprised 60.1% of all GAS. During the initial COVID-19 peak, all GAS surgeries nearly halved, with breast augmentations dropping to 15.3% of pre-pandemic volumes. White patients constituted a significantly higher proportion of GAS patients during the initial COVID-19 peak than in 2019 (74.7% vs. 61.0%, p = 0.014). Post-vaccine, GAS levels surged, exceeding pre-pandemic volumes by 45.5% and initial peak levels by 188.5%. The overall complication rate was 4.9%, and was significantly associated with older age, increased operative time, feminizing and masculinizing genital surgeries, and hysterectomies. The initial COVID-19 peak showed no significant correlations with surgical complications.ConclusionsGAS volume temporarily decreased during the initial COVID-19 outbreak and has since rebounded and surpassed pre-pandemic levels, corresponding with past-decade trends. Complication risks remained consistent despite the pandemic, though the results highlight potentially significant race-based disparities in GAS access during COVID-19.Important PointsDuring the COVID-19 pandemic, public health measures led to severe volume reductions in gender-affirming surgical (GAS) procedures.Since the initial COVID-19 peak, GAS volumes have fully recovered and surpassed pre-pandemic volumes.Surgical complication rates for various GAS procedures were within expected ranges, emphasizing the overall safety of these surgeries.The study's results highlight racial disparities in undergoing GAS during the COVID-19 pandemic, with White patients disproportionately represented among those who had surgery during the COVID-19 lockdown.Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of contents or the online Instructions to Authors www.springer.com/00266.
引用
收藏
页码:3520 / 3529
页数:10
相关论文
共 49 条
[1]   A review of gender affirmation surgery: What we know, and what we need to know [J].
Akhavan, Arya Andre ;
Sandhu, Shabaaz ;
Ndem, Idorenyin ;
Ogunleye, Adeyemi A. .
SURGERY, 2021, 170 (01) :336-340
[2]   Association Between Gender-Affirming Surgeries and Mental Health Outcomes [J].
Almazan, Anthony N. ;
Keuroghlian, Alex S. .
JAMA SURGERY, 2021, 156 (07) :611-618
[3]  
American College of Surgeons ASoA Association of periOperative Registered Nurses American Hospital Association, 2020, Joint Statement Roadmap for Resuming Elective Surgery after COVID-19 Pandemic
[4]  
[Anonymous], 2020, COVID-19: Recommendations for management of elective surgical procedures
[5]  
[Anonymous], 2020, Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak
[6]   The Future of Transgender Coverage [J].
Baker, Kellan E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (19) :1801-1804
[7]  
Beckwith Noor, 2017, Transgend Health, V2, P156, DOI [10.1089/trgh.2017.0028, 10.1089/trgh.2017.0028]
[8]  
Byne William, 2018, Transgend Health, V3, P57, DOI [10.1089/trgh.2017.0053, 10.1089/trgh.2017.0053]
[9]   Sexual and Gender Minority Health Equity in the Biden Administration [J].
Cahill, Sean ;
Miller, Amitai S. ;
Keuroghlian, Alex S. .
JAMA HEALTH FORUM, 2022, 3 (02)
[10]   Temporal Trends in Gender-Affirming Surgery Among Transgender Patients in the United States [J].
Canner, Joseph K. ;
Harfouch, Omar ;
Kodadek, Lisa M. ;
Pelaez, Danielle ;
Coon, Devin ;
Offodile, Anaeze C., II ;
Haider, Adil H. ;
Lau, Brandyn D. .
JAMA SURGERY, 2018, 153 (07) :609-616